XOLAAM, oral suspension in a vial bottle, 250 ml
Active ingredients: Aluminum hydroxide, Magnesium hydroxide
Commercialized according to BDPM
Oral suspensionbottle, 250 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XOLAAM, suspension buvable en flacon
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 250 ml
- Marketing authorisation holder
- SUN PHARMA FRANCE
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Aug 2022
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64795700CIP73421819CIP133400934218194Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALUMINIUM (OXYDE D') HYDRATÉsuspension | 3,500 g · 100 ml | SA |
| HYDROXYDE DE MAGNÉSIUMsuspension | 4,000 g · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.